DE60329225D1 - Botulinumneurotoxin-b-rezeptoren und ihreverwendung - Google Patents
Botulinumneurotoxin-b-rezeptoren und ihreverwendungInfo
- Publication number
- DE60329225D1 DE60329225D1 DE60329225T DE60329225T DE60329225D1 DE 60329225 D1 DE60329225 D1 DE 60329225D1 DE 60329225 T DE60329225 T DE 60329225T DE 60329225 T DE60329225 T DE 60329225T DE 60329225 D1 DE60329225 D1 DE 60329225D1
- Authority
- DE
- Germany
- Prior art keywords
- bont
- syt
- methods
- binding
- disclosed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108010074523 rimabotulinumtoxinB Proteins 0.000 title abstract 2
- 101710117524 Botulinum neurotoxin type B Proteins 0.000 abstract 10
- 238000000034 method Methods 0.000 abstract 4
- 230000001413 cellular effect Effects 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 150000002270 gangliosides Chemical class 0.000 abstract 2
- 230000001988 toxicity Effects 0.000 abstract 2
- 231100000419 toxicity Toxicity 0.000 abstract 2
- 241000193155 Clostridium botulinum Species 0.000 abstract 1
- 108010055170 Synaptotagmin I Proteins 0.000 abstract 1
- 108010055445 Synaptotagmin II Proteins 0.000 abstract 1
- 102100036417 Synaptotagmin-1 Human genes 0.000 abstract 1
- 102100036151 Synaptotagmin-2 Human genes 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42295102P | 2002-10-31 | 2002-10-31 | |
| US49812803P | 2003-08-27 | 2003-08-27 | |
| PCT/US2003/034348 WO2005016233A2 (en) | 2002-10-31 | 2003-10-28 | Botulinum neurotoxin b receptors and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60329225D1 true DE60329225D1 (de) | 2009-10-22 |
Family
ID=34197667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60329225T Expired - Lifetime DE60329225D1 (de) | 2002-10-31 | 2003-10-28 | Botulinumneurotoxin-b-rezeptoren und ihreverwendung |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20040191887A1 (de) |
| EP (1) | EP1578382B1 (de) |
| JP (2) | JP2006512090A (de) |
| AT (1) | ATE442161T1 (de) |
| AU (1) | AU2003304419A1 (de) |
| CA (1) | CA2504532C (de) |
| DE (1) | DE60329225D1 (de) |
| ES (1) | ES2333319T3 (de) |
| IL (1) | IL167943A (de) |
| WO (1) | WO2005016233A2 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60329225D1 (de) * | 2002-10-31 | 2009-10-22 | Wisconsin Alumni Res Found | Botulinumneurotoxin-b-rezeptoren und ihreverwendung |
| US7341843B2 (en) * | 2003-04-11 | 2008-03-11 | Allergan, Inc. | Botulinum toxin A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy |
| US8748106B2 (en) * | 2005-04-18 | 2014-06-10 | Bal Ram Singh | Methods of identifying a compound that increases or decreases the interaction of Hn-33 with synaptotagmin II |
| DE102005019302A1 (de) | 2005-04-26 | 2006-11-16 | Toxogen Gmbh | Carrier zum Targeting von Nervenzellen |
| US7985554B2 (en) | 2005-10-14 | 2011-07-26 | Wisconsin Alumni Research Foundation | Botulinum neurotoxin A receptor and the use thereof |
| DE102005051789B4 (de) | 2005-10-28 | 2014-08-07 | Toxogen Gmbh | Der Botulinus Neurotoxin A Proteinrezeptor und seine Anwendungen |
| US9303284B2 (en) | 2007-09-14 | 2016-04-05 | Biomadison, Inc. | Resonance energy transfer assay with cleavage sequence and spacer |
| US10908146B2 (en) | 2011-06-01 | 2021-02-02 | Biomadison, Inc. | Compositions and methods for improving sensitivity in cell based assays |
| US11325954B2 (en) | 2011-06-01 | 2022-05-10 | Biomadison, Inc. | Compositions and methods for stability testing of botulinum toxin |
| US12422428B2 (en) | 2011-06-01 | 2025-09-23 | Biomadison, Inc. | Compositions and methods for cell-based assays |
| LT2715355T (lt) | 2011-06-01 | 2017-06-12 | Biomadison, Inc. | Ne fret (fluorescencijos rezonansinės energijos perdavimas) būdu atliekamas botulino tyrimas |
| US9303285B2 (en) | 2012-01-04 | 2016-04-05 | Biomadison, Inc. | Methods and compounds for increasing sensitivity of botulinum assays |
| ES2818986T5 (es) | 2013-08-09 | 2024-01-25 | Biomadison Inc | Ensayo de toxina botulínica con sensibilidad mejorada |
| AU2023259903A1 (en) * | 2022-04-25 | 2024-11-21 | Jiksak Bioengineering, Inc. | Targeting agent |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6994995B1 (en) * | 2001-03-16 | 2006-02-07 | Lexicon Genetics Incorporated | Human synaptotagmin and polynucleotides encoding the same |
| US8022172B2 (en) * | 2001-08-28 | 2011-09-20 | Allergan, Inc. | Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity |
| US7176278B2 (en) * | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
| DE60329225D1 (de) * | 2002-10-31 | 2009-10-22 | Wisconsin Alumni Res Found | Botulinumneurotoxin-b-rezeptoren und ihreverwendung |
| WO2005076785A2 (en) * | 2003-12-19 | 2005-08-25 | Wisconsin Alumni Research Foundation | Method and compositions for detecting botulinum neurotoxin |
| AU2006340711C1 (en) * | 2005-04-05 | 2013-02-07 | Allergan, Inc. | Clostridial toxin activity assays |
| ES2426194T3 (es) * | 2005-08-02 | 2013-10-21 | Planet Biotechnology, Inc. | Proteínas quiméricas del receptor de toxina mejoradas y proteínas quiméricas del receptor de toxina para el tratamiento y la prevención de anthrax |
| US7985554B2 (en) * | 2005-10-14 | 2011-07-26 | Wisconsin Alumni Research Foundation | Botulinum neurotoxin A receptor and the use thereof |
| WO2013011055A1 (en) * | 2011-07-19 | 2013-01-24 | ETH Zürich | Means and methods for determining clostridial neurotoxins |
-
2003
- 2003-10-28 DE DE60329225T patent/DE60329225D1/de not_active Expired - Lifetime
- 2003-10-28 CA CA2504532A patent/CA2504532C/en not_active Expired - Fee Related
- 2003-10-28 ES ES03816739T patent/ES2333319T3/es not_active Expired - Lifetime
- 2003-10-28 WO PCT/US2003/034348 patent/WO2005016233A2/en not_active Ceased
- 2003-10-28 EP EP03816739A patent/EP1578382B1/de not_active Expired - Lifetime
- 2003-10-28 AU AU2003304419A patent/AU2003304419A1/en not_active Abandoned
- 2003-10-28 AT AT03816739T patent/ATE442161T1/de not_active IP Right Cessation
- 2003-10-28 JP JP2005507928A patent/JP2006512090A/ja active Pending
- 2003-10-28 US US10/695,577 patent/US20040191887A1/en not_active Abandoned
-
2005
- 2005-04-10 IL IL167943A patent/IL167943A/en unknown
-
2009
- 2009-10-01 JP JP2009229744A patent/JP2010006833A/ja active Pending
-
2011
- 2011-10-26 US US13/281,501 patent/US8617573B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006512090A (ja) | 2006-04-13 |
| EP1578382A2 (de) | 2005-09-28 |
| US20120082672A1 (en) | 2012-04-05 |
| AU2003304419A1 (en) | 2005-03-07 |
| WO2005016233A2 (en) | 2005-02-24 |
| US8617573B2 (en) | 2013-12-31 |
| ATE442161T1 (de) | 2009-09-15 |
| EP1578382B1 (de) | 2009-09-09 |
| US20040191887A1 (en) | 2004-09-30 |
| IL167943A (en) | 2010-12-30 |
| WO2005016233A3 (en) | 2005-08-18 |
| ES2333319T3 (es) | 2010-02-19 |
| JP2010006833A (ja) | 2010-01-14 |
| CA2504532A1 (en) | 2005-02-24 |
| EP1578382A4 (de) | 2007-08-29 |
| CA2504532C (en) | 2014-09-16 |
| AU2003304419A8 (en) | 2005-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60329225D1 (de) | Botulinumneurotoxin-b-rezeptoren und ihreverwendung | |
| CY1124802T1 (el) | Δεσμευτικοι παραγοντες σκληροστινης | |
| CY1122686T1 (el) | Ανταγωνιστικοι εκλεκτικοι παραγοντες συνδεσης της πρωτεϊνης συνδεσης οστεοπροτεγερινης | |
| DE59910084D1 (de) | Organische Salze von Isoleucyl-Thiazolidin und -Pyrrolidin und ihre Verwendung als Dipeptidylpeptidase-Inhibitoren | |
| EP1687283A4 (de) | Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung | |
| ATE466080T1 (de) | Formulierungen und verfahren zum denaturieren von proteinen | |
| DE602004006433D1 (de) | Pyrrol-substituierte indole als inhibitoren von pai-1 | |
| ATE480643T1 (de) | Homogener nachweis von analyten | |
| CR10147A (es) | "ligandos que tienen especificidad de enlace para vegf y/o egfr y métodos de uso de los mismos" | |
| DE69919537D1 (de) | Arylsubstituierte olefinische amine und ihre verwendung als cholinergische rezeptoragonisten | |
| DE60100620D1 (de) | Gezielte elektrochemische reduktion von halogenierten 4-amino-picolinsäuren | |
| DE60139544D1 (de) | Veränderte, fluoreszierende proteine | |
| ATE443775T1 (de) | Hif-prolylhydroxylase-aktivitätstest | |
| ATE466283T1 (de) | Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen | |
| ATE365801T1 (de) | Modulierung durch il-tif/interleukin-21 | |
| ATE487792T1 (de) | Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen | |
| DE60107416D1 (de) | Adnf mischungen zur verbesserung der lernfähigkeit und der gedächtnisfunktion | |
| DE60332029D1 (de) | Screening-verfahren für kognitive erweiterungsvorrichtungen | |
| DE69919684D1 (de) | Verwendung von isolierten domänen des type-iv-kollagens zur änderung der zell- und gewebewechselwirkung | |
| EA200401032A1 (ru) | Антиинфарктные молекулы | |
| DE60140563D1 (de) | Verfahren und zusammensetzungen zum aussortieren und/oder nachweis von mikroorganismen | |
| ATE540047T1 (de) | Gedächtnisveränderung durch beeinflussung der funktion von staufen | |
| WO2002095354A3 (en) | Methods and labeled molecules for determining ligand binding to steroid receptors | |
| ATE382098T1 (de) | Zellbindende nukleinsäuremoleküle (aptamere) | |
| DE69535039D1 (de) | Cytoplasmische tyrosin kinase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |